explore -WSS

explore

author：Wikipedia 2025-09-30 22:28:00 - browse：175

Photo illustration of three children against a blue background. -- health coverage from STAT — The Pashai children (from left): Abubakar, Mohammad, and Sufyan. Illustration: STAT; Photo Courtesy

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home they’d ever known. They did not know when, if ever, they would set foot there again.

Three years later, the Pashais are fearing for their family’s lives once again. This time the existential threat they face isn’t war, but a pair of faulty genes, silently passed down through their families for generations before detonating on American soil.

In October, Mohammad was diagnosed with a rare inherited disorder — metachromatic leukodystrophy. Genetic tests revealed his youngest brother, Sufyan, though he’s showing no symptoms, also has the disease. There’s a potential cure for Sufyan, a company offering it free of charge, and a team of doctors in Minnesota ready to administer it. But the Medicaid program in the Pashais’ new home state of Texas has said it won’t cover the cost of even an initial consult to confirm he’s a good candidate for the treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

WSS

Paxlovid should be available without a positive Covid test

Vaccine advisory panel ACIP left half staffed by HHS

Biogen Alzheimer’s drug launch off to slow start

Doctors' information doesn't help them choose wisely when sick

Senators start work on Medicare physician payment reform

After a drawn out lobbying fight, ARPA

explore

explore

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Vaccine advisory panel ACIP left half staffed by HHS

Supreme Court strikes down use of affirmative action

Menendez indictment could see pharma lose a key ally

Wildfire smoke exposes gaps in outdoor worker protections

Address the ethical violations that led to 'Three Identical Strangers'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Peter Hotez and the public health issue of online harassment

Doctors' information doesn't help them choose wisely when sick

entertainment

How one patient went off dialysis — and others can too

A disappointing year of Humira biosimilars

How digital tools helped lower hypertension in marginalized patients

Senators start work on Medicare physician payment reform

Medicare Advantage proposed rates disappoint insurers

Medicaid, Medicare dual

knowledge

focus

focus

focus